Work

Phase II Evaluation of Sunitinib Malate, a Multi-Targeted Inhibitor of Receptor Tyrosine Kinases, in Patients with Myelofibrosis.

Year: 2007

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v110.11.3552.3552

Authors: Constantine S. Tam, Deborah A. Thomas, Farhad Ravandi, Catherine D. Richardson, Gautam Borthakur, Jan A. Burger, Elihu Estey, Hagop Kantarjian, Srdan Verstovsek

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Myeloproliferative Neoplasms: Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2994582402

FWCI:

Cites:

Cited by:

Related to: 10